SCHEMBL24079256

SCHEMBL24079256

Cc1ccc(OC(C)C)c(OCCN(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.57
ALDH1A1 P00352 5/20 0.57
TDP1 Q9NUW8 3/20 0.57
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
GAA P10253 1/20 0.48
HTR7 P34969 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPBWR1 P48145 1/20 0.41
MCHR1 Q99705 1/20 0.41
BRPF1 P55201 1/20 0.40
ADRA2A P08913 1/20 0.40
PKM P14618 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1D P25100 1/20 0.40
HTR2C P28335 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351005 0.82 ACHE (0.57) KDM4EALDH1A1TDP1CYP1A2CYP2D6
SCHEMBL23876585 0.82 KDM4E (0.42) KDM4EALDH1A1TDP1CYP1A2CYP2D6
SCHEMBL24079254 0.81 L3MBTL1 (0.47) KDM4EALDH1A1TDP1CYP1A2CYP2C19
SCHEMBL23876693 0.80 KDM4E (0.82) KDM4EALDH1A1TDP1HTR7SMN1; SMN2
SCHEMBL13433991 0.79 POLB (0.46) KDM4EALDH1A1TDP1CYP1A2CYP2C19
SCHEMBL10493570 0.79 ALDH1A1 (0.84) KDM4EALDH1A1TDP1CYP1A2CYP2D6
SCHEMBL13232444 0.79 L3MBTL1 (0.61) KDM4EALDH1A1TDP1CYP1A2CYP2D6
SCHEMBL21079236 0.79 KDM4E (0.65) KDM4EALDH1A1TDP1GAASMN1; SMN2
SCHEMBL14000157 0.78 KDM4E (0.56) KDM4EALDH1A1TDP1CYP1A2CYP2D6
SCHEMBL13019317 0.78 MAPT (0.47) KDM4EALDH1A1TDP1GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192886-B2 S1P1 agonist and application thereof MEDSHINE DISCOVERY INC. (CN) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192886-B2 S1P1 agonist and application thereof S1PR1, S1PR2, S1PR3 KDM4E 3986/4885ALDH1A1 2418/4885TDP1 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.